Navigation Links
MedShape Solutions, Inc. Announces Commercialization of SBIR Funded Technology: Receives Purchasing Preference in Federally Funded Hospitals and Health Care Facilities
Date:3/5/2010

ATLANTA, March 5 /PRNewswire/ -- MedShape Solutions announced today that it is pursuing Phase III SBIR awards and has received preferred vendor status at Veterans Health Administration Hospitals and other Federally funded hospitals for its MORPHIX ™ Shape Memory Suture Anchor.  The MORPHIX device was developed with financial assistance through NIH/NIAMS Grants # 1R43AR056154-01, 2R44AR056154-02, 5R44AR056154-03.  The MORPHIX Anchor is being highlighted and launched nationally at the American Academy of Orthopedic Surgeons meeting in New Orleans, March 10-13, 2010.

The Small Business Act Policy Directive provides that "Government owned, contractor operated facilities….give preference including sole source awards to the awardee that developed the technology."  Section 4 (c) (7)  The Directive also states that "the competition for SBIR Phase I and Phase II awards satisfies any competition requirement of the Armed Services Procurement Act, The Federal Property and Administrative Services Act and the Competition in Contracting Act."  Section 4 (c) (3)

"The development of the MORPHIX Suture Anchor with SBIR support was a textbook case of how a partnership in development should occur.  The grant funding received was critical to the development success and eventual commercialization of this innovative technology," stated Chris Fair, Chief Operations Officer of MedShape Solutions.

MedShape Solutions initial product is the MORPHIX Suture Anchor made from proprietary shape memory PEEK Altera.   "We anticipate releasing additional technologies in the months ahead that were  supported via SBIR Phase I & Phase II awards for their development.  These technologies will also receive the same preferred supplier status within their product category," stated Kurt Jacobus, PhD, President & CEO of MedShape Solutions.

MedShape Solutions is a privately held company focused on developing orthopedic devices from proprietary shape memory technology.  You may find more information at www.medshape.com.

If you are a government purchasing group and would like additional information, please contact Chris Fair, Chief Operating Officer of MedShape Solutions at (404) 249-9155 or send an email to gov@medshape.com .

SOURCE MedShape Solutions, Inc.

Back to top

RELATED LINKS
http://www.medshape.com

'/>"/>

SOURCE MedShape Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MedShape Solutions, Inc. Announces First FDA-cleared Shape Memory PEEK Device; Closing of $10M Equity Offering
2. RESolutions Rapid Enrollment Solutions, LLC Announces Launch of Novel Patient Recruitment Web Site - Clinical Trial Spotlight™
3. NexInfo Solutions, Inc. Selected by Beckman Coulter to Design and Streamline Global Sales & Operations Planning Processes
4. Hospira Announces New Contract With MedAssets for Intravenous Solutions, Renewal of Infusion Devices Agreement
5. Jovianna DiCarlo Named ConsentSolutions, Inc. President & Chief Executive Officer
6. Karen Walton-Bowen Joins Abt Bio-Pharma Solutions, Inc., as Senior Director, Biometrics
7. Mentice, Inc. and Education Management Solutions, Inc. Form OEM Partnership
8. Abt Bio-Pharma Solutions, Inc. Names Nandini Hadker as Executive Director, Succeeding Susan Windham-Bannister
9. VaxGen Sells Anthrax Vaccine Program and Related Assets and Technology to Emergent BioSolutions, Inc.
10. Premier Research Group plc and Octagon Research Solutions, Inc. Announce Strategic Partnership
11. Abt Associates Clinical Trials Announces Name Change to Abt Bio-Pharma Solutions, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... 2017 , ... DaVita Clinical Research (DCR), a ... device development, and Prism Clinical Research , a leader in providing fully ... Clinical Trials (VCT) has been selected by both companies as an exclusive ...
(Date:1/19/2017)... Acupath Laboratories, Inc., a leading provider of ... Executive Committee that will guide the company,s vision and ... Cucci , a 15-year veteran of the anatomic pathology ... to Chief Sales Officer .  Prior to joining ... sales leadership roles at several leading lab industry organizations ...
(Date:1/18/2017)... According to a new market research report "In situ Hybridization Market ... User (Molecular Diagnostic Laboratories, Academic and Research Institutions) - Global Forecast to 2021" ... 2021 from USD 557.1 Million in 2016, growing at a CAGR of 5.8%. ... ... MarketsandMarkets Logo ...
(Date:1/18/2017)... --  Parent Project Muscular Dystrophy (PPMD) , a nonprofit ... dystrophy (Duchenne) , today announced a $600,000 grant to ... (NJIT) and Talem Technologies (Talem) as part of the ... assist people living with Duchenne. PPMD is funding a ... computer, software, a force sensor and a motor – ...
Breaking Biology Technology:
(Date:12/22/2016)... December 22, 2016 SuperCom (NASDAQ: ... solutions for the e-Government, Public Safety, HealthCare, and Finance sectors announced ... has been selected to implement and deploy a community-based supportive services ... Northern California , further expanding its presence in the state. ... This new program, ...
(Date:12/19/2016)... España y TORONTO , 19 de diciembre de ... Biologics Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo ... varios tipos de tumor en 2017, con múltiples sitios previstos a ... ... con objetivo en el factor inhibidor de leucemia (LIF), una citoquina ...
(Date:12/16/2016)... , Dec. 16, 2016 The global wearable medical device ... billion by 2021 from USD 5.31 billion in 2016, at a ... ... driven by technological advancements in medical devices, launch of a growing ... for wireless connectivity among healthcare providers, and increasing focus on physical ...
Breaking Biology News(10 mins):